|
PBCA NP coated with Polysorbate 80
|
dalargin (analgesic)
|
[133, 134, 137]
|
|
PBCA NP coated with Polysorbate 80
|
doxorubicin (DOX) (anti-tumour antibiotic)
|
[139, 146, 147]
|
|
PBCA NP coated with Polysorbate 80
|
kytorphin (analgesic)
|
[141]
|
|
PBCA NP
|
NMDA receptor antagonist MRZ 2/576 (antagonist)
|
[140]
|
|
PBCA NP coated with Polysorbate 80
|
tubocurarine (Increased BBB permeability)
|
[142]
|
|
PEG-PHDCA
|
PrPres Specific Drug in Prion Disease
|
[143]
|
|
PBCA NP coated with Polysorbate 80
|
tacrine (Anti Alzheimer's Drug)
|
[144]
|
|
PBCA NP coated with Polysorbate 80
|
rivastigmine (Anti Alzheimer's Drug)
|
[145]
|
|
PBCA NP coated with Polysorbate 80
|
gemcitabine (anti glioma drug)
|
[148]
|
|
DMAEMA/HEMA (pH sensitive)
|
paclitaxel
|
[75]
|
|
LDC-polysorbate 80 NPs
|
diminazene (anti human African trypanosomiasis (HAT))
|
[153]
|
|
DO-FUdR-SLN
|
5-fluoro-2'-deoxyuridine (FUdR) (Very efficient in brain targeting)
|
[154]
|
|
PBCA NPs, MMA-SPM NPs, and SLNs
|
stavudine (D4T), delavirdine (DLV), and saquinavir (SQV) (anti HIV agents and enhanced BBB permeability)
|
[155]
|
|
PBCA NPs coated with apolipoprotein B and E
|
loperamide and dalargin (increased BBB permeability)
|
[77]
|
